Skip to main content
. 2014 Jul 29;6:186. doi: 10.3389/fnagi.2014.00186

Table 1.

Comparisons of plasma amylin in humans in the absence of diabetes.

Diagnoses Controls MCI Alzheimer's disease
N = 104 N = 82 N = 26
Median, pM/L 23.5 14.8 17.6
Q1, Q3 13.3, 47.8 8.3, 31.7 7.9, 27.9
p-values 0.01 0.05

Median (Q1, Q3) is used to describe the distributions of plasma amylin. Using Wilcoxon rank sum test, the comparisons are shown between a disease subgroup and the controls.